FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/11/010377 [Registered on: 06/11/2017] Trial Registered Retrospectively
Last Modified On: 31/10/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to study the effect of ayurvedic drug compound, Nimbashatak Vati in patient with intestinal worm infestation 
Scientific Title of Study   Clinical study on the management of krimiroga (intestinal worm infestation) in children with Nimbashatak Vati 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mahesh Patel 
Designation  P.G.Scholar 
Affiliation  Parul Institute of Ayurveda 
Address  Parul Institute of Ayurveda P.O. Limda Tal-Waghodia Dist-Vadodara pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  9909597376  
Fax    
Email  drmjp007@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunil Changle 
Designation  Professor 
Affiliation  Parul Institute of Ayurveda 
Address  Parul Institute of Ayurveda P.O. Limda Tal-Waghodia Dist-Vadodara pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  9687613916  
Fax    
Email  Sunilchangle16@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mahesh Patel 
Designation  P.G.Scholar 
Affiliation  Parul Institute of Ayurveda 
Address  Parul Institute of Ayurveda P.O. Limda Tal-Waghodia Dist-Vadodara pincode-391760

Vadodara
GUJARAT
391760
India 
Phone  9909597376  
Fax    
Email  drmjp007@gmail.com  
 
Source of Monetary or Material Support  
Parul Ayurveda Hospital, A/P Limada Tal Waghodia Dist Vadodara Gujarat. 
 
Primary Sponsor  
Name  Mahesh Patel 
Address  Parul Institute of Ayurveda P.O.Limda Tal-Waghodia Dist-Vadodara Gujarat 391760 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Mahesh Patel  Parul Institute of Ayurvedal  Kaumarbhritya department in Ayurveda hospital
Vadodara
GUJARAT 
9909597376

drmjp007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Parul Institute of Ayurveda-Institutional Ethics Committee on Human Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  krimi(intestinal worm infestation),  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nimbashatak vati 500mg  child dose as per age will be calculated according to youngs formula. Time of drug administration-at night with luke warm water 
Comparator Agent  Tab Albendazole 400mg  Tab Albendazole 400mg single dose, repeat 400mg dose after 15 days 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  15.00 Year(s)
Gender  Both 
Details  children with clinical feature of krimiroga and positive stool report for intestinal helminthic infestation (cyst and ova) 
 
ExclusionCriteria 
Details  patient with major congenital disorders and chronic debilitating disease. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Changes in subsidence of the clinical sign and symptoms with negative stool report for ova and cyst.  28 days in both intervention and control grroup 
 
Secondary Outcome  
Outcome  TimePoints 
improvement in general health condition and quality of life.  After 30 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "29"
Final Enrollment numbers achieved (India)="29" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   01/09/2016 
Date of Study Completion (India) 10/01/2017 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is a randomized controlled clinical study to evaluate the efficacy of Nimbashatak vati (tablet prepared out of 6 anti-helminthic drugs mentioned in ayurvedic treaties- Yog-Ratnakar) and tab Albendazole in the management of krimi(intestinal worm infestation).The primary outcome measures are changes in subsidence of the clinical sign and symptoms measured at baseline and after 2 week in control group and  abscence of recurrence during follow up. Changes in stool report in baseline ,after 4 weeks of intervention, and for 2 times during follow up period will also be conducted to assess the efficacy of treatment to prevent the recurrence. Secondary outcome measures are changes in general health condition like body weight ,Agni bala, Deha bala, Chetas bala at Baseline and after 4 weeks. 
Close